Evidence map›Paper›PMID 39921554›Full record

ArticleStatistics in medicine2025

Instability of the AUROC of Clinical Prediction Models.

Florian D van Leeuwen, Ewout W Steyerberg, David van Klaveren, Ben Wessler, David M Kent, Erik W van Zwet

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Translational cancer research · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florian D van LeeuwenDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0009-0009-7092-2848
Ewout W SteyerbergDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-7787-0122
David van KlaverenDepartment of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.ORCID 0000-0002-2096-606X
Ben WesslerPredictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.
David M KentPredictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.
Erik W van ZwetDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-5537-3179

Funding

Palliative Care for High-Risk TAVR Patients: The Impact of MultimorbidityK23AG055667 · NIA · TUFTS MEDICAL CENTER · PI WESSLER, BENJAMIN SETH · 2018 to 2022
$948k
NIA NIH HHS K23 AG055667
6 · The paper itself

Abstract

backgroundExternal validations are essential to assess the performance of a clinical prediction model (CPM) before deployment. Apart from model misspecification, also differences in patient population, the standard of care, predictor definitions, and other factors influence a model's discriminative ability, as commonly quantified by the AUC (or c-statistic). We aimed to quantify the variation in AUCs across sets of external validation studies and propose ways to adjust expectations of a model's performance in a new setting.

methodsThe Tufts-PACE CPM Registry holds a collection of CPMs for prognosis in cardiovascular disease. We analyzed the AUC estimates of 469 CPMs with at least one external validation. Combined, these CPMs had a total of 1603 external validations reported in the literature. For each CPM and its associated set of validation studies, we performed a random-effects meta-analysis to estimate the between-study standard deviation

resultsThe 469 CPMs included in our study had a median of 2 external validations with an IQR of [1-3]. The estimated distribution of

conclusionDue to large heterogeneity among the validated AUC values of a CPM, there is great irreducible uncertainty in predicting the AUC in a new setting. This uncertainty is underestimated by existing methods. The proposed empirical Bayes approach addresses this problem which merits wide application in judging the validity of prediction models.

Indexed as

Area Under CurveModels, StatisticalROC CurveBayes TheoremCardiovascular DiseasesHumansPrognosisRegistriesclinical prediction modelsCPMempirical Bayesheterogeneitymeta‐analysis

Identifiers

PMID39921554
PMCPMC11806515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.